Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM4I1JP)

Drug Name
Polyethylene glycol Drug Info
Synonyms
ETHYLENE GLYCOL; Ethane-1,2-diol; 1,2-ethanediol; 107-21-1; glycol; monoethylene glycol; 1,2-Dihydroxyethane; 2-hydroxyethanol; Glycol alcohol; polyethylene glycol; Ethylene alcohol; Macrogol; Fridex; Tescol; Ethylene dihydrate; Norkool; Macrogol 400 BPC; Dowtherm SR 1; Zerex; Ucar 17; Lutrol-9; ethyleneglycol; ethanediol; Aethylenglykol; Polyethylene glycol 200; Glycol, ethylene-; 1,2-Ethandiol; Glycols, polyethylene; Caswell No. 441; Ethylenglycol; Lutrol; Aethylenglykol [German]; Polyethylene glycol 600; 146AR; UNII-FC72KVT52F
Indication
Disease Entry ICD 11 Status REF
Constipation DD91.1 Approved [1]
Cross-matching ID
PubChem CID
174
ChEBI ID
CHEBI:30742
CAS Number
CAS 107-21-1
TTD Drug ID
DM4I1JP
INTEDE Drug ID
DR1312

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Metabolized By Alcohol dehydrogenase class-III (ADH5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [7]
NADH DM5NM6E Parkinson disease 8A00.0 Approved [8]
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [9]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [10]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [11]
Diazepam DM08E9O Alcohol withdrawal Approved [12]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [13]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [14]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [15]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [16]
Methotrexate DM2TEOL Anterior urethra cancer Approved [17]
Quercetin DM3NC4M Obesity 5B81 Approved [18]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 1A2 (CYP1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zolmitriptan DM1IB4Q Migraine 8A80 Approved [19]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [19]
Etoricoxib DM6A4NW Rheumatoid arthritis FA20 Approved [19]
Capsaicin DMGMF6V Back pain ME84.Z Approved [20]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [21]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [22]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [23]
Zileuton DMVRIC2 Allergic asthma CA23.0 Approved [24]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [25]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [10]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Integrin beta-1 (ITGB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [26]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [27]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [28]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [29]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [31]
Fructose DM43AN2 Vomiting MD90 Approved [32]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [33]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [34]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [35]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-1 (CDH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [36]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [37]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [38]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [39]
Quercetin DM3NC4M Obesity 5B81 Approved [40]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [41]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [33]
Panobinostat DM58WKG Chronic graft versus host disease Approved [42]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Retinal dehydrogenase 2 (ALDH1A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Panobinostat DM58WKG Chronic graft versus host disease Approved [42]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [6]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [44]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Metoclopramide DMFA5MY Nausea MD90 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Somatotropin (GH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [46]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [47]
Cyproheptadine DM92AH3 Allergic rhinitis CA08.0 Approved [48]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Sodium oxybate DMBOV5P Narcolepsy 7A20 Approved [49]
Ethanol DMDRQZU Chronic pain MG30 Approved [50]
Connexyn DMF29Q5 Attention deficit hyperactivity disorder 6A05.Z Approved [51]
Gamma Hydroxybutyric Acid DMGBKVD Narcolepsy 7A20 Approved [52]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [53]
Octreotide DMHIDCJ Acromegaly 5A60.0 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein Hox-B7 (HOXB7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [55]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [6]
Testosterone enanthate DMB6871 N. A. N. A. Approved [56]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [57]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [58]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [59]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 2 (CCL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [60]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [61]
Gefitinib DM15F0X Colon adenocarcinoma Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [63]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [64]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [65]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [66]
Methotrexate DM2TEOL Anterior urethra cancer Approved [67]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [68]
Quercetin DM3NC4M Obesity 5B81 Approved [69]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Paired box protein Pax-3 (PAX3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [70]
Panobinostat DM58WKG Chronic graft versus host disease Approved [42]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [71]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Folic Acid DMEMBJC Colorectal carcinoma Approved [72]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [73]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [74]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein MOX-1 (MEOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [27]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Panobinostat DM58WKG Chronic graft versus host disease Approved [42]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [75]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [76]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor 15 (TCF15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [6]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [6]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [77]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Oligodendrocyte transcription factor 3 (OLIG3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [73]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Ethanol DMDRQZU Chronic pain MG30 Approved [78]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hepatitis A virus cellular receptor 1 (HAVCR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [79]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [80]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [81]
Gentamicin DMKINJO Bacteremia 1A73 Approved [82]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [84]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [79]
Arsenic DMTL2Y1 N. A. N. A. Approved [85]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [86]
Urethane DM7NSI0 N. A. N. A. Phase 4 [87]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eyes absent homolog 1 (EYA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [88]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [33]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [6]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Forkhead box protein C2 (FOXC2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [89]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [6]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Panobinostat DM58WKG Chronic graft versus host disease Approved [42]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [6]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurogenin-2 (NEUROG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [33]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [6]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [6]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [6]
Leflunomide DMR8ONJ Arthritis FA20 Approved [90]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Dabigatran DMDI6R4 Stroke 8B20 Approved [6]
Folic Acid DMEMBJC Colorectal carcinoma Approved [73]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [6]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By All-trans-retinol dehydrogenase ADH4 (ADH4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [40]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [91]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [91]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [93]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [95]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alcohol dehydrogenase 1C (ADH1C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [97]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [98]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [91]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [99]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [100]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [99]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [101]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [91]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By All-trans-retinol dehydrogenase ADH7 (ADH7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [102]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [86]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [103]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [77]
2-Propanol, Isopropanol DML5O0H Discovery agent N.A. Investigative [4]
Drug(s) Affected By Alcohol dehydrogenase 1A (ADH1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [97]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [27]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [104]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [100]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [105]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [93]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [106]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [107]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By All-trans-retinol dehydrogenase ADH1B (ADH1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [108]
Selenium DM25CGV N. A. N. A. Approved [103]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [91]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [90]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [45]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [93]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [107]
Flucloxacillin DMNUWST Bacterial infection 1A00-1C4Z Approved [110]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Alcohol dehydrogenase class-III (ADH5) Main DME DEIOH6A ADHX_HUMAN Substrate [2]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Albumin (ALB) OTVMM513 ALBU_HUMAN Protein Interaction/Cellular Processes [3]
Alcohol dehydrogenase 1A (ADH1A) OTTS983E ADH1A_HUMAN Biotransformations [4]
Alcohol dehydrogenase 1C (ADH1C) OTO1DV7F ADH1G_HUMAN Biotransformations [4]
All-trans-retinol dehydrogenase ADH1B (ADH1B) OTV3TB81 ADH1B_HUMAN Biotransformations [4]
All-trans-retinol dehydrogenase ADH4 (ADH4) OTKDKKNG ADH4_HUMAN Biotransformations [4]
All-trans-retinol dehydrogenase ADH7 (ADH7) OTO2ZATJ ADH7_HUMAN Biotransformations [4]
C-C motif chemokine 2 (CCL2) OTAD2HEL CCL2_HUMAN Gene/Protein Processing [5]
Cadherin-1 (CDH1) OTFJMXPM CADH1_HUMAN Gene/Protein Processing [3]
Cytochrome P450 1A2 (CYP1A2) OTLLBX48 CP1A2_HUMAN Gene/Protein Processing [3]
Eyes absent homolog 1 (EYA1) OTHU807A EYA1_HUMAN Gene/Protein Processing [6]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies. Drug Metab Dispos. 2007 Jan;35(1):9-16.
3 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
4 Oxidation of methanol, ethylene glycol, and isopropanol with human alcohol dehydrogenases and the inhibition by ethanol and 4-methylpyrazole. Chem Biol Interact. 2011 May 30;191(1-3):26-31. doi: 10.1016/j.cbi.2010.12.005. Epub 2010 Dec 15.
5 Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury. Toxicology. 2011 Nov 28;290(1):82-8. doi: 10.1016/j.tox.2011.08.019. Epub 2011 Sep 3.
6 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
7 Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. Alcohol Clin Exp Res. 2006 Jul;30(7):1132-42.
8 Conformational changes and catalysis by alcohol dehydrogenase. Arch Biochem Biophys. 2010 Jan 1;493(1):3-12.
9 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
10 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
11 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
12 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
13 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
14 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
15 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
16 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
17 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
18 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.
19 In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol. 2008 Aug;103(2):157-65.
20 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
21 Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicol Lett. 2018 Sep 15;294:27-36.
22 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
23 Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.
24 Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. Drug Metab Dispos. 2003 Nov;31(11):1352-60.
25 Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. J Med Chem. 2005 Jun 2;48(11):3808-15.
26 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
27 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
28 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
29 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
30 Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheumatol. 2014 Dec;33(12):1815-21. doi: 10.1007/s10067-014-2807-8. Epub 2014 Oct 24.
31 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
32 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
33 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
34 Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
35 Suppressive effect of hydroquinone, a benzene metabolite, on in vitro inflammatory responses mediated by macrophages, monocytes, and lymphocytes. Mediators Inflamm. 2008;2008:298010. doi: 10.1155/2008/298010. Epub 2009 Jan 14.
36 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
37 Nitric oxide causes anoikis through attenuation of E-cadherin and activation of caspase-3 in human gastric carcinoma AZ-521 cells infected with Mycoplasma hyorhinis. J Vet Med Sci. 2010 Jul;72(7):869-74.
38 Induced differentiation in HT29, a human colon adenocarcinoma cell line. J Cell Sci. 1999 Aug;112 ( Pt 16):2657-66. doi: 10.1242/jcs.112.16.2657.
39 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
40 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
41 Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009 Mar 13;380(3):614-9. doi: 10.1016/j.bbrc.2009.01.134. Epub 2009 Jan 27.
42 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
43 Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis. Mol Cell Endocrinol. 2013 Sep 5;377(1-2):84-92. doi: 10.1016/j.mce.2013.07.002. Epub 2013 Jul 10.
44 The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012 Jan 5;195(1):52-60.
45 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
46 Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine. Clin Pharmacol Ther. 1989 Jul;46(1):103-9. doi: 10.1038/clpt.1989.113.
47 Phosphatidylinositol 4-OH kinase is a downstream target of neuronal calcium sensor-1 in enhancing exocytosis in neuroendocrine cells. J Biol Chem. 2003 Feb 21;278(8):6075-84. doi: 10.1074/jbc.M204702200. Epub 2002 Dec 5.
48 [Toxicity of cyproheptadine. Side effects and accidental overdosage (author's transl)]. Monatsschr Kinderheilkd (1902). 1978 Mar;126(3):123-6.
49 Failure of gammahydroxy butyric acid to stimulate growth hormone secretion in cocaine addicts. Neuropeptides. 1997 Oct;31(5):459-62. doi: 10.1016/s0143-4179(97)90040-8.
50 Metal-catalyzed oxidation of human growth hormone: modulation by solvent-induced changes of protein conformation. J Pharm Sci. 2001 Jan;90(1):58-69. doi: 10.1002/1520-6017(200101)90:1<58::aid-jps7>3.0.co;2-w.
51 Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans. Hypertension. 1984 Sep-Oct;6(5 Pt 2):II57-62. doi: 10.1161/01.hyp.6.5_pt_2.ii57.
52 Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. Neuropeptides. 1999 Dec;33(6):522-5. doi: 10.1054/npep.1999.0773.
53 Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers. Addict Behav. 2005 May;30(4):859-64. doi: 10.1016/j.addbeh.2004.08.019.
54 Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. Eur J Clin Invest. 1992 Jul;22(7):494-502. doi: 10.1111/j.1365-2362.1992.tb01496.x.
55 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
56 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
57 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
58 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
59 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
60 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
61 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
62 Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 1;338:1-9. doi: 10.1016/j.toxlet.2020.11.011. Epub 2020 Nov 25.
63 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
64 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
65 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
66 Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016 Feb 12;291(7):3639-47. doi: 10.1074/jbc.M115.679704. Epub 2015 Dec 18.
67 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
68 Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1194-9. doi: 10.1161/01.atv.0000022694.16328.cc.
69 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
70 All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J. 2007 Jan;274(2):498-511. doi: 10.1111/j.1742-4658.2006.05597.x.
71 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
72 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
73 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
74 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
75 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
76 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
77 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
78 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
79 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
80 Transporter-dependent cytotoxicity of antiviral drugs in primary cultures of human proximal tubular cells. Toxicology. 2018 Jul 1;404-405:10-24. doi: 10.1016/j.tox.2018.05.002. Epub 2018 May 5.
81 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
82 In vitro evaluation of biomarkers of nephrotoxicity through gene expression using gentamicin. J Biochem Mol Toxicol. 2018 Sep;32(9):e22189. doi: 10.1002/jbt.22189. Epub 2018 Jul 10.
83 Urinary proteomic profiling reveals diclofenac-induced renal injury and hepatic regeneration in mice. Toxicol Appl Pharmacol. 2013 Jun 1;269(2):141-9. doi: 10.1016/j.taap.2013.03.005. Epub 2013 Mar 16.
84 In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicol Lett. 2013 Mar 13;217(3):235-42. doi: 10.1016/j.toxlet.2012.12.015. Epub 2012 Dec 31.
85 Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. J Appl Toxicol. 2023 Aug;43(8):1214-1224. doi: 10.1002/jat.4457. Epub 2023 Mar 11.
86 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
87 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
88 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
89 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
90 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
91 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
92 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
93 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
94 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
95 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
96 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
97 An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci. 2013 Mar;132(1):131-41.
98 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
99 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
100 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
101 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
102 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
103 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
104 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
105 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
106 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
107 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
108 Differences in the activities of resveratrol and ascorbic acid in protection of ethanol-induced oxidative DNA damage in human peripheral lymphocytes. Food Chem Toxicol. 2012 Feb;50(2):168-74.
109 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
110 Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury. Toxicol Sci. 2023 Mar 20;192(1):106-116. doi: 10.1093/toxsci/kfad015.